SHARE: +/-: 0.08 SEK / Bid: 6.68 SEK / Ask: 6.82 SEK / Price: 6.68 SEK / High: 6.90 SEK / Low: 6.34 SEK / Quantity: 54 786 / Turnover: 356 342 SEK / 2020-08-13 15:29 (CEST)
 

Spago Pix

Improved tumor visualization

Tumorad

Tumor selective radiation treatment

Stock information

Share, calendar & reports

Spago Nanomedical develops nanomaterials for improved cancer diagnostics and treatment

Optimizing cancer diagnostics and treatment

Spago Nanomedical develops nanomedical products for cancer diagnostics and treatment. The company’s main activities are focused on developing SpagoPix, a nanomedical contrast agent for MRI, and the therapeutic development project Tumorad, for tumor selective radionuclide treatment.